Improving Academic Biobank Value and Sustainability Through an Outputs Focus.
- Publisher:
- Elsevier BV
- Publication Type:
- Journal Article
- Citation:
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2020, 23, (8), pp. 1072-1078
- Issue Date:
- 2020-08-02
Closed Access
| Filename | Description | Size | |||
|---|---|---|---|---|---|
| 1-s2.0-S109830152032115X-main.pdf | Published version | 728.49 kB |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Although it is generally accepted that human tissue biobanks are important to facilitate progress in health and medical research, many academic biobanks face sustainability challenges. We propose that biobank sustainability is challenged by a lack of available data describing the outputs and benefits that are produced by biobanks, as reflected by a dearth of publications that enumerate biobank outputs. We further propose that boosting the available information on biobank outputs and using a broader range of output metrics will permit economic analyses such as cost-consequence analyses of biobank activity. Output metrics and cost-consequence analyses can allow biobanks to achieve efficiencies, and improve the quality and/or quantity of their outputs. In turn, biobank output measures provide all stakeholders with explicit and accountable data on biobank value, which could contribute to the evolution of biobank operations to best match research needs, and mitigate some threats to biobank sustainability.
Please use this identifier to cite or link to this item: